These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 27330379)

  • 1. Dilemmas of the causality assessment tools in the diagnosis of adverse drug reactions.
    Khan LM; Al-Harthi SE; Osman AM; Sattar MA; Ali AS
    Saudi Pharm J; 2016 Jul; 24(4):485-93. PubMed ID: 27330379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward Kidney-Specific Causality Assessment Tool.
    Kaya M; Duru M; Gulmez SE
    Clin Ther; 2022 Jul; 44(7):e59-e75. PubMed ID: 35725506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of three methods (consensual expert judgement, algorithmic and probabilistic approaches) of causality assessment of adverse drug reactions: an assessment using reports made to a French pharmacovigilance centre.
    Théophile H; Arimone Y; Miremont-Salamé G; Moore N; Fourrier-Réglat A; Haramburu F; Bégaud B
    Drug Saf; 2010 Nov; 33(11):1045-54. PubMed ID: 20925441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methods for causality assessment of adverse drug reactions: a systematic review.
    Agbabiaka TB; Savović J; Ernst E
    Drug Saf; 2008; 31(1):21-37. PubMed ID: 18095744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A tailor-made approach for causality assessment for ADR reports on drugs and vaccines.
    Oosterhuis I; Zweers P; Rümke H; Muller-Hansma A; van Puijenbroek EP
    Pharmacoepidemiol Drug Saf; 2019 Apr; 28(4):544-550. PubMed ID: 30168222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MOdified NARanjo Causality Scale for ICSRs (MONARCSi): A Decision Support Tool for Safety Scientists.
    Comfort S; Dorrell D; Meireis S; Fine J
    Drug Saf; 2018 Nov; 41(11):1073-1085. PubMed ID: 29876835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse drug reaction causality assessment tools for drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: room for improvement.
    Goldman JL; Chung WH; Lee BR; Chen CB; Lu CW; Hoetzenecker W; Micheletti R; Yasuda SU; Margolis DJ; Shear NH; Struewing JP; Pirmohamed M
    Eur J Clin Pharmacol; 2019 Aug; 75(8):1135-1141. PubMed ID: 30918988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Causality assessment of adverse drug reaction reports using an expert-defined Bayesian network.
    Rodrigues PP; Ferreira-Santos D; Silva A; Polónia J; Ribeiro-Vaz I
    Artif Intell Med; 2018 Sep; 91():12-22. PubMed ID: 30077492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mobile App Design, Development, and Publication for Adverse Drug Reaction Assessments of Causality, Severity, and Preventability.
    Ithnin M; Mohd Rani MD; Abd Latif Z; Kani P; Syaiful A; Nor Aripin KN; Tengku Mohd TAM
    JMIR Mhealth Uhealth; 2017 May; 5(5):e78. PubMed ID: 28559222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary Results of a Novel Algorithmic Method Aiming to Support Initial Causality Assessment of Routine Pharmacovigilance Case Reports for Medication-Induced Liver Injury: The PV-RUCAM.
    Scalfaro E; Streefkerk HJ; Merz M; Meier C; Lewis D
    Drug Saf; 2017 Aug; 40(8):715-727. PubMed ID: 28508325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Causality assessment in pharmacovigilance: The French method and its successive updates.
    Miremont-Salamé G; Théophile H; Haramburu F; Bégaud B
    Therapie; 2016 Apr; 71(2):179-86. PubMed ID: 27080836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric pharmacovigilance in an institute of national importance: Journey has just begun.
    Sharma PK; Misra AK; Gupta N; Khera D; Gupta A; Khera P
    Indian J Pharmacol; 2017; 49(5):390-395. PubMed ID: 29515280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of a novel causality assessment scale for adverse events in non-small cell lung carcinoma patients treated with platinum and pemetrexed doublet chemotherapy.
    Sharma JB; Krishnamurthy MN; Awase A; Joshi A; Patil V; Noronha V; Prabhash K; Gota V
    Ther Adv Drug Saf; 2021; 12():2042098621991280. PubMed ID: 33628419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety reports on the off-label use of baclofen for alcohol-dependence: recommendations to improve causality assessment.
    Rolland B; Auffret M; Franchitto N
    Expert Opin Drug Saf; 2016 Jun; 15(6):747-51. PubMed ID: 26987987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating Twitter as a complementary data source for pharmacovigilance.
    Lardon J; Bellet F; Aboukhamis R; Asfari H; Souvignet J; Jaulent MC; Beyens MN; Lillo-LeLouët A; Bousquet C
    Expert Opin Drug Saf; 2018 Aug; 17(8):763-774. PubMed ID: 29991282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agreement of expert judgment in causality assessment of adverse drug reactions.
    Arimone Y; Bégaud B; Miremont-Salamé G; Fourrier-Réglat A; Moore N; Molimard M; Haramburu F
    Eur J Clin Pharmacol; 2005 May; 61(3):169-73. PubMed ID: 15827761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A quantitative approach of using genetic algorithm in designing a probability scoring system of an adverse drug reaction assessment system.
    Koh Y; Yap CW; Li SC
    Int J Med Inform; 2008 Jun; 77(6):421-30. PubMed ID: 17921048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can causality assessment fulfill the new European definition of adverse drug reaction? A review of methods used in spontaneous reporting.
    Mascolo A; Scavone C; Sessa M; di Mauro G; Cimmaruta D; Orlando V; Rossi F; Sportiello L; Capuano A
    Pharmacol Res; 2017 Sep; 123():122-129. PubMed ID: 28694146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-Related Adverse Drug Events in Neonates: Recognition and Assessment.
    Allegaert K; van den Anker J
    J Clin Pharmacol; 2021 Jun; 61 Suppl 1(Suppl 1):S152-S160. PubMed ID: 34185907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.